M. V. Golshmid

M. V. Golshmid

Auto-generated profile, based on publicly available information

M. V. Golshmid

Russian Medical Academy of Continuous Professional Education

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SGS. R. Gilyarevsky
S. R. Gilyarevsky
NVN. K. Vereina
N. K. Vereina
MGM. V. Golshmid
M. V. Golshmid
The article is devoted to the discussion of modern approaches to the use of laboratory methods to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which it may be reasonable to use data on the blood concentration of DOACs are given, including very old age, a marked deviation from the norm of body weight or impaired renal function. Data on the role of measuring the blood level of DOACs are considered in cases of the development of diseases or complications in which information is required on the preservation of the anticoagulant effect of DOACs, for example, in the development of severe bleeding or the need for urgent surgical intervention. The advantages and limitations of modern laboratory methods for assessing the blood concentration of DOACs are discussed. It is emphasized that one of the main advantages of using DOACs is the absence of the need to monitor laboratory parameters in most patients. Data from pharmacological studies are presented that may be useful in explaining the mechanisms that determine the higher safety of some DOACs compared to others. Promising methods for assessing the blood level of DOACs, as well as the possibility of using less specific reagents for assessing the concentration of DOACs, are considered. The possibility of using less specific, but more accessible methods for assessing the blood concentration of factor Xa inhibitors, in particular, a reagent for assessing the level of the antifactor, which is used to determine the blood level of heparin, is being considered. The opinions of experts on the role of assessing the blood level of DOACs and the possibility of tactics for selecting doses of DOACs based on laboratory analysis data are given.

23 April 2019 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
SGS. R. Gilyarevsky
S. R. Gilyarevsky
MGM. V. Golshmid
M. V. Golshmid
ИКИ. М. Кузьмина
И. М. Кузьмина
NBN. G. Bendeliani
N. G. Bendeliani
The article reports the modern tactics of treating patients with chronic heart failure and concomitant anemia. The results of the most important randomized clinical trials that are the basis for developing approaches to the treatment of anemia in such cases are discussed. Attention is also paid to unresolved problems in the treatment of anemia in patients with heart failure. The data on the intravenous administration of iron preparations as the most effective approach to the treatment of anemia in patients with heart failure in the presence of iron defciency are given. The main provisions of modern clinical guidelines on the management of patients with heart failure and anemia are considered.

29 May 2021 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
SGS. R. Gilyarevskij
S. R. Gilyarevskij
NBN. G. Bendeliani
N. G. Bendeliani
MGM. V. Golshmid
M. V. Golshmid
IKI. M. Kuz’mIna
I. M. Kuz’mIna
IAI. G. Andreeva
I. G. Andreeva
ПРИМЕНЕНИЕ КОМБИНИРОВАННЫХ ПРЕПАРАТОВ С ПОСТОЯННЫМИ ДОЗАМИ АНТИГИПЕРТЕНЗИВНЫХ СРЕДСТВ КАК НАЧАЛЬНАЯ ТАКТИКА ЛЕЧЕНИЯ ПРИ ПОВЫШЕННОМ УРОВНЕ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ: ДОКАЗАННЫЕ ФАКТЫ И МНЕНИЕ ЭКСПЕРТОВ


8 September 2022 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SGS. R. Gilyarevsky
S. R. Gilyarevsky
MGM. V. Golshmid
M. V. Golshmid
NBN. G. Bendeliani
N. G. Bendeliani
Aim. To evaluate the effect of taking a single pill combination of amlodipine, lisinopril and rosuvastatin on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) in hypertensive patients with or without severe hypercholesterolemia.Material and methods. Articles published in Russian were selected for analysis. Six articles that met the criteria for inclusion in a systematic review were found by searching the eLibrary database for the keyword "equamer". The results of 5 observational clinical studies were presented in these articles. The effectiveness of the fixed combination of amlodipine, lisinopril and rosuvastatin was assessed mainly by changes in the level of systolic and diastolic blood pressure, the concentration of LDL cholesterol. In addition, the effects of fixed-dose amlodipine, lisinopril, and rosuvastatin on central aortic pressure and its increment index, as well as carotid-femoral pulse wave velocity, were studied in part of the studies. The effect of the fixed combination of amlodipine, lisinopril and rosuvastatin on blood pressure and LDL-C concentration, as well as on these additional indicators, in patients who had a coronavirus infection with severe lung damage was studied in one study.Results. Evidence from a systematic review demonstrates the efficacy of single pill combination amlodipine, lisinopril and rosuvastatin in reducing blood pressure and LDL-C in a wide range of patients with different baseline risk of developing cardiovascular complications and different baseline levels of blood pressure and LDL-C.Conclusion. The data obtained confirm the feasibility of more frequent prescription of the single pill combination of amlodipine, lisinopril and rosuvastatin in clinical practice for the treatment of hypertensive patients with high or moderate risk of developing cardiovascular diseases, including patients with concomitant hypercholesterolemia.

18 October 2025 in Primary Health Care (Russian Federation)
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
EAE. B. Avalueva
E. B. Avalueva
IBIgor G. Bakulin
Igor G. Bakulin
BBB. А. Bakirov
B. А. Bakirov
IBI. I. Baranov
I. I. Baranov
ESEvgenia Shikh
Evgenia Shikh
Iron deficiency anemia is a multietiological disease, the development of which is associated with iron deficiency due to its impaired intake, absorption or increased losses, characterized by microcytosis and hypochromic anemia. The practical guide describes in detail the etiology, paraclinical diagnostics, management of patients in various clinical situations. Guidelines are intended for primary health care professionals, including internists, general practitioners, cardiologists, gastroenterologists and other specialists providing care to patients with iron deficiency anemia.